99 related articles for article (PubMed ID: 2751317)
21. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
[TBL] [Abstract][Full Text] [Related]
22. [Overcoming of ACNU resistance in a subline of rat glioma in vitro and in vivo by reserpine].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2141-6. PubMed ID: 3459396
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
[TBL] [Abstract][Full Text] [Related]
24. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
25. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effect and peritumoral brain edema formation in relation to MX2, ACNU, and doxorubicin therapy: a comparative analysis using rodent models of gliomas.
Mima T; Mostafa MG; Mori K
Neurol Res; 2000 Dec; 22(8):819-24. PubMed ID: 11149245
[TBL] [Abstract][Full Text] [Related]
27. [Combination therapy with HU IFN-beta and ACNU against malignant brain tumors, Part 1. Experimental study in vitro].
Yoshida J; Wakabayashi T; Inoue I; Kageyama N
Gan To Kagaku Ryoho; 1985 Jan; 12(1):99-104. PubMed ID: 3855355
[TBL] [Abstract][Full Text] [Related]
28. The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cells.
Meise R; Tomicic MT; Kaina B; Christmann M
Biochim Biophys Acta; 2012 Jul; 1823(7):1199-207. PubMed ID: 22609303
[TBL] [Abstract][Full Text] [Related]
29. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
[TBL] [Abstract][Full Text] [Related]
30. Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
Leggas M; Stewart CF; Woo MH; Fouladi M; Cheshire PJ; Peterson JK; Friedman HS; Billups C; Houghton PJ
Clin Cancer Res; 2002 Sep; 8(9):3000-7. PubMed ID: 12231547
[TBL] [Abstract][Full Text] [Related]
31. In vitro sensitivity of nitrosourea-induced neurogenic tumors to ACNU.
Kida Y; Cravioto H; Hochwald G; Ransohoff J
Anticancer Res; 1982; 2(1-2):79-87. PubMed ID: 6956245
[TBL] [Abstract][Full Text] [Related]
32. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
Takahashi H; Adachi K; Yamaguchi F; Teramoto A
Anticancer Res; 1999; 19(5B):4151-5. PubMed ID: 10628367
[TBL] [Abstract][Full Text] [Related]
33. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
[TBL] [Abstract][Full Text] [Related]
35. The effect of taurolidine on brain tumor cells.
Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
[TBL] [Abstract][Full Text] [Related]
36. [Meningeal gliomatosis models as a chemosensitivity assay system].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Nakata Y; Sakamoto Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3):458-63. PubMed ID: 6584085
[TBL] [Abstract][Full Text] [Related]
37. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
38. [Effect of ACNU, a water-soluble nitrosourea, on cell cycle of cultured glioma cells--flow cytometric analysis].
Fujiwara T; Nakasone S; Matsumoto K; Ohnishi R; Tabuchi K; Nishimoto A
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2055-61. PubMed ID: 6577816
[TBL] [Abstract][Full Text] [Related]
39. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.
Roth W; Isenmann S; Naumann U; Kügler S; Bähr M; Dichgans J; Ashkenazi A; Weller M
Biochem Biophys Res Commun; 1999 Nov; 265(2):479-83. PubMed ID: 10558893
[TBL] [Abstract][Full Text] [Related]
40. [The effect of hyperthermia and antitumor drugs on brain tumor cell lines].
Tanaka T; Kobayashi T; Kida Y; Kageyama N
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2993-7. PubMed ID: 3464229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
